Jui‐Ling Hsu

785 total citations
30 papers, 551 citations indexed

About

Jui‐Ling Hsu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jui‐Ling Hsu has authored 30 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Jui‐Ling Hsu's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Ubiquitin and proteasome pathways (5 papers) and DNA Repair Mechanisms (4 papers). Jui‐Ling Hsu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Ubiquitin and proteasome pathways (5 papers) and DNA Repair Mechanisms (4 papers). Jui‐Ling Hsu collaborates with scholars based in Taiwan, United States and Russia. Jui‐Ling Hsu's co-authors include Jih‐Hwa Guh, Lih‐Ching Hsu, Chau‐Jong Wang, Fen‐Pi Chou, Yih‐Shou Hsieh, Yunn‐Fang Ho, Shun‐Chieh Young, Hsun‐Shuo Chang, She‐Hung Chan and Shih‐Ping Liu and has published in prestigious journals such as PLoS ONE, Molecules and Biochemical Pharmacology.

In The Last Decade

Jui‐Ling Hsu

29 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jui‐Ling Hsu Taiwan 15 325 125 117 110 73 30 551
Yi-Shih Ma Taiwan 13 423 1.3× 96 0.8× 125 1.1× 93 0.8× 66 0.9× 14 735
Dipita Bhakta-Guha India 10 376 1.2× 65 0.5× 109 0.9× 209 1.9× 68 0.9× 18 761
Yaxiong Tang China 15 436 1.3× 80 0.6× 117 1.0× 111 1.0× 48 0.7× 42 775
Ji‐Ae Shin South Korea 17 476 1.5× 103 0.8× 96 0.8× 93 0.8× 57 0.8× 59 729
Clarissa Esmeralda Halim Singapore 7 349 1.1× 57 0.5× 109 0.9× 155 1.4× 102 1.4× 9 640
Weili Min China 17 299 0.9× 98 0.8× 110 0.9× 132 1.2× 37 0.5× 26 591
Munju Cho South Korea 11 447 1.4× 72 0.6× 68 0.6× 123 1.1× 50 0.7× 14 638
Quangen Gao China 14 403 1.2× 76 0.6× 118 1.0× 102 0.9× 41 0.6× 17 624
Amara Maryam China 13 388 1.2× 55 0.4× 156 1.3× 90 0.8× 77 1.1× 18 675
Yao Wu China 14 299 0.9× 82 0.7× 99 0.8× 64 0.6× 60 0.8× 29 526

Countries citing papers authored by Jui‐Ling Hsu

Since Specialization
Citations

This map shows the geographic impact of Jui‐Ling Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui‐Ling Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui‐Ling Hsu more than expected).

Fields of papers citing papers by Jui‐Ling Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui‐Ling Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui‐Ling Hsu. The network helps show where Jui‐Ling Hsu may publish in the future.

Co-authorship network of co-authors of Jui‐Ling Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Jui‐Ling Hsu. A scholar is included among the top collaborators of Jui‐Ling Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui‐Ling Hsu. Jui‐Ling Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hsu, Jui‐Ling, She‐Hung Chan, Lih‐Ching Hsu, et al.. (2024). A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer. The Prostate. 84(6). 605–619. 2 indexed citations
3.
4.
Jiang, Yi‐Huei, She‐Hung Chan, Ih‐Sheng Chen, et al.. (2024). Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(9). 6533–6550. 1 indexed citations
5.
Li, Yu‐Hsuan, Chao‐Wu Yu, Jui‐Ling Hsu, et al.. (2021). Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity. Bioorganic Chemistry. 110. 104813–104813. 5 indexed citations
6.
Hsu, Jui‐Ling, Elena Marchesi, Massimo L. Capobianco, et al.. (2020). Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells. Frontiers in Pharmacology. 11. 599067–599067. 30 indexed citations
7.
Li, Yuliang, et al.. (2019). The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells. Frontiers in Pharmacology. 10. 1311–1311. 37 indexed citations
8.
9.
10.
11.
12.
Hsu, Jui‐Ling, et al.. (2014). Calanquinone A induces anti-glioblastoma activity through glutathione-involved DNA damage and AMPK activation. European Journal of Pharmacology. 730. 90–101. 4 indexed citations
13.
Chen, Yen‐Hui, Jui‐Ling Hsu, She‐Hung Chan, et al.. (2013). Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(1). 33–45. 31 indexed citations
14.
15.
16.
17.
Hsu, Jui‐Ling, et al.. (2009). Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78. Naunyn-Schmiedeberg s Archives of Pharmacology. 380(5). 373–382. 31 indexed citations
18.
Hsieh, Yih‐Shou, et al.. (2006). Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicology and Applied Pharmacology. 214(1). 8–15. 134 indexed citations
19.
Young, Shun‐Chieh, et al.. (2006). Protection effect of piper betel leaf extract against carbon tetrachloride-induced liver fibrosis in rats. Archives of Toxicology. 81(1). 45–55. 29 indexed citations
20.
Young, Shun‐Chieh, Chau‐Jong Wang, Jeng‐Dong Hsu, Jui‐Ling Hsu, & Fen‐Pi Chou. (2005). Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract. Archives of Toxicology. 80(6). 319–327. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi-Shih Ma Breakdown of academic impact, for papers by Dipita Bhakta-Guha Breakdown of academic impact, for papers by Yaxiong Tang Breakdown of academic impact, for papers by Ji‐Ae Shin Breakdown of academic impact, for papers by Clarissa Esmeralda Halim Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Munju Cho Breakdown of academic impact, for papers by Quangen Gao Breakdown of academic impact, for papers by Amara Maryam Breakdown of academic impact, for papers by Yao Wu
Rankless by CCL
2026